Show simple item record

dc.contributor.authorPotter, S
dc.contributor.authorThomson, H J
dc.contributor.authorGreenwood, R J
dc.contributor.authorHopwood, Penelope
dc.contributor.authorWinters, Z E
dc.date.accessioned2009-11-05T11:50:33Z
dc.date.available2009-11-05T11:50:33Z
dc.date.issued2009-06
dc.identifier.citationHealth-related quality of life assessment after breast reconstruction. 2009, 96 (6):613-20 Br J Surgen
dc.identifier.issn1365-2168
dc.identifier.pmid19434704
dc.identifier.doi10.1002/bjs.6605
dc.identifier.urihttp://hdl.handle.net/10541/85405
dc.description.abstractBACKGROUND: Health-related quality of life (HRQL) is an important outcome following breast reconstruction. This study evaluated current methods of HRQL assessment in patients undergoing latissimus dorsi breast reconstruction, hypothesizing that early surgical morbidity would be reflected by poorer HRQL scores. METHODS: Patients completed the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 and breast module (QLQ-BR23), the Functional Assessment of Cancer Therapy (FACT) general measure, and breast module and arm subscale (FACT-B + 4), and the Body Image Scale and Hospital Anxiety and Depression Scale (HADS) 3 months after surgery. They also reported additional HRQL problems not included in the questionnaires. HRQL scores were compared between patients with and without early surgical morbidity. RESULTS: Sixty women completed the questionnaires, of whom 25 (42 per cent) experienced complications. All EORTC and FACT subscale and HADS scores were similar in patients with or without morbidity. Women with complications were twice as likely to report feeling less feminine and dissatisfied with the appearance of their scar than those without problems. Thirty-two women (53 per cent) complained of problems not covered by the questionnaires, most commonly donor-site morbidity. CONCLUSION: Existing HRQL instruments are not sufficiently sensitive to detect clinically relevant problems following breast reconstruction.
dc.language.isoenen
dc.subjectBreast Canceren
dc.subject.meshBody Image
dc.subject.meshBreast Neoplasms
dc.subject.meshCross-Sectional Studies
dc.subject.meshFemale
dc.subject.meshHealth Status
dc.subject.meshHumans
dc.subject.meshMammaplasty
dc.subject.meshMiddle Aged
dc.subject.meshPostoperative Complications
dc.subject.meshPsychiatric Status Rating Scales
dc.subject.meshQuality of Life
dc.subject.meshQuestionnaires
dc.subject.meshSensitivity and Specificity
dc.subject.meshTreatment Outcome
dc.titleHealth-related quality of life assessment after breast reconstruction.en
dc.typeArticleen
dc.contributor.departmentDepartment of Clinical Sciences at South Bristol, University of Bristol, Bristol Royal Infirmary, Bristol, UK. Shelley.Potter@bristol.ac.uken
dc.identifier.journalThe British Journal of Surgeryen
html.description.abstractBACKGROUND: Health-related quality of life (HRQL) is an important outcome following breast reconstruction. This study evaluated current methods of HRQL assessment in patients undergoing latissimus dorsi breast reconstruction, hypothesizing that early surgical morbidity would be reflected by poorer HRQL scores. METHODS: Patients completed the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 and breast module (QLQ-BR23), the Functional Assessment of Cancer Therapy (FACT) general measure, and breast module and arm subscale (FACT-B + 4), and the Body Image Scale and Hospital Anxiety and Depression Scale (HADS) 3 months after surgery. They also reported additional HRQL problems not included in the questionnaires. HRQL scores were compared between patients with and without early surgical morbidity. RESULTS: Sixty women completed the questionnaires, of whom 25 (42 per cent) experienced complications. All EORTC and FACT subscale and HADS scores were similar in patients with or without morbidity. Women with complications were twice as likely to report feeling less feminine and dissatisfied with the appearance of their scar than those without problems. Thirty-two women (53 per cent) complained of problems not covered by the questionnaires, most commonly donor-site morbidity. CONCLUSION: Existing HRQL instruments are not sufficiently sensitive to detect clinically relevant problems following breast reconstruction.


This item appears in the following Collection(s)

Show simple item record